BibTex format
@inproceedings{Jagannath:2021:10.1182/blood-2021-146003,
author = {Jagannath, S and Facon, T and Badros, AZ and Levy, M and Moreau, P and Delimpasi, S and Simonova, M and Spicka, I and Kriachok, I and Gavriatopoulou, M and Pylypenko, H and Auner, HW and Leleu, X and Doronin, V and Usenko, G and Hajek, R and Benjamin, R and Dolai, TK and Sinha, DK and Venner, CP and Garg, M and Mesa, MG and Jurczyszyn, A and Robak, T and Galli, M and Wallington-Beddoe, CT and Radinoff, A and Salogub, G and Stevens, D and Basu, S and Liberati, AM and Quach, H and Marinova, VSG and Bila, JS and Katodritou, E and De, Castro A and Chai, Y and Van, Domelen DR and Mishal, M and Bentur, OS and Shah, J and Shacham, S and Kauffman, MG and Grosicki, S and Richardson, PG},
doi = {10.1182/blood-2021-146003},
pages = {3793--+},
publisher = {AMER SOC HEMATOLOGY},
title = {Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study},
url = {http://dx.doi.org/10.1182/blood-2021-146003},
year = {2021}
}